Carbidopa Tablets, 25 mg (Alvogen Inc.)
Welcome to the PulseAid listing for the Carbidopa Tablets, 25 mg drug offered from Alvogen Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen Inc. |
NON-PROPRIETARY NAME: | Carbidopa Tablets, 25 mg |
SUBSTANCE NAME: | CARBIDOPA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-01-26 |
END MARKETING DATE: | 0000-00-00 |
Carbidopa Tablets, 25 mg HUMAN PRESCRIPTION DRUG Details:
Item Description | Carbidopa Tablets, 25 mg from Alvogen Inc. |
LABELER NAME: | Alvogen Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2016-01-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-332_5d1077f9-2b99-add8-55b9-e3b30b736e5a |
PRODUCT NDC: | 47781-332 |
APPLICATION NUMBER: | ANDA204291 |
Other CARBIDOPA Pharmaceutical Manufacturers / Labelers: